BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 29198659)

  • 21. De Novo Human Herpesvirus 8 Tumors Induced by Rituximab in Autoimmune or Inflammatory Systemic Diseases.
    Périer A; Savey L; Marcelin AG; Serve P; Saadoun D; Barete S
    Arthritis Rheumatol; 2017 Nov; 69(11):2241-2246. PubMed ID: 28719723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamics of Epstein-Barr viral load after hematopoietic stem cell transplantation and effect of preemptive rituximab therapy.
    Raberahona M; Wackenheim C; Germi R; Carré M; Bulabois CE; Thiébaut A; Lupo J; Semenova T; Cahn JY; Morand P; Epaulard O
    Transpl Infect Dis; 2016 Dec; 18(6):889-895. PubMed ID: 27696681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Invasive aspergillosis in kidney transplant recipients: a cohort study.
    Pérez-Sáez MJ; Mir M; Montero MM; Crespo M; Montero N; Gómez J; Horcajada JP; Pascual J
    Exp Clin Transplant; 2014 Apr; 12(2):101-5. PubMed ID: 24702140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Posttransplant Lymphoproliferative Disorders in Irish Renal Transplant Recipients: Insights From a National Observational Study.
    OʼRegan JA; Prendeville S; McCaughan JA; Traynor C; OʼBrien FJ; Ward FL; OʼDonovan D; Kennedy C; Berzan E; Kinsella S; Williams Y; OʼKelly P; Deady S; Comber H; Leader M; Conlon PJ
    Transplantation; 2017 Mar; 101(3):657-663. PubMed ID: 27214265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
    Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
    G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cryptococcal infections in solid organ transplant recipients over a 15-year period at a state transplant center.
    Gassiep I; McDougall D; Douglas J; Francis R; Playford EG
    Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27875016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rituximab and chronic plasmapheresis therapy of nephrotic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis.
    Rodríguez-Ferrero M; Ampuero J; Anaya F
    Transplant Proc; 2009; 41(6):2406-8. PubMed ID: 19715934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rituximab-associated hypogammaglobulinemia: incidence, predictors and outcomes in patients with multi-system autoimmune disease.
    Roberts DM; Jones RB; Smith RM; Alberici F; Kumaratne DS; Burns S; Jayne DR
    J Autoimmun; 2015 Feb; 57():60-5. PubMed ID: 25556904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypogammaglobulinemia and risk of severe infection in kidney transplant recipients.
    Augusto JF; Garnier AS; Demiselle J; Langs V; Picquet J; Legall R; Sargentini C; Culty T; Poli C; Ammi M; Ducancelle A; Chevailler A; Duveau A; Subra JF; Sayegh J
    Transpl Infect Dis; 2016 Oct; 18(5):741-751. PubMed ID: 27509578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of infectious complications and their risk factors in the first year after renal transplantation.
    Sousa SR; Galante NZ; Barbosa DA; Pestana JO
    J Bras Nefrol; 2010 Mar; 32(1):75-82. PubMed ID: 21448523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rituximab-Related Late-Onset Neutropenia in Kidney Transplant Recipients Treated for Antibody-Mediated Acute Rejection.
    Ahmadi F; Dashti-Khavidaki S; Khatami MR; Lessan-Pezeshki M; Khalili H; Khosravi M
    Exp Clin Transplant; 2017 Aug; 15(4):414-419. PubMed ID: 27796249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytomegalovirus infection following renal transplantation in patients administered low-dose rituximab induction therapy.
    Nishida H; Ishida H; Tanaka T; Amano H; Omoto K; Shirakawa H; Shimizu T; Iida S; Toki D; Yamaguchi Y; Tanabe K
    Transpl Int; 2009 Oct; 22(10):961-9. PubMed ID: 19619177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Risk of Severe Infections Following Rituximab Administration in Patients With Autoimmune Kidney Diseases: Austrian ABCDE Registry Analysis.
    Odler B; Windpessl M; Krall M; Steiner M; Riedl R; Hebesberger C; Ursli M; Zitt E; Lhotta K; Antlanger M; Cejka D; Gauckler P; Wiesholzer M; Saemann M; Rosenkranz AR; Eller K; Kronbichler A
    Front Immunol; 2021; 12():760708. PubMed ID: 34777374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Skin malignancies in renal transplant recipients: a Brazilian center registry.
    Falsarella PM; Alves-Filho G; Mazzali M
    Transplant Proc; 2008 Apr; 40(3):767-8. PubMed ID: 18455011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: data from the French Autoimmunity and Rituximab registry.
    Terrier B; Launay D; Kaplanski G; Hot A; Larroche C; Cathébras P; Combe B; de Jaureguiberry JP; Meyer O; Schaeverbeke T; Somogyi A; Tricot L; Zénone T; Ravaud P; Gottenberg JE; Mariette X; Cacoub P
    Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1787-95. PubMed ID: 20740617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rituximab is not a "magic drug" in post-transplant recurrence of nephrotic syndrome.
    Grenda R; Jarmużek W; Rubik J; Piątosa B; Prokurat S
    Eur J Pediatr; 2016 Sep; 175(9):1133-1137. PubMed ID: 27364906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytomegalovirus infection in autologous stem cell transplant recipients in the era of rituximab.
    Jain T; John J; Kotecha A; Deol A; Saliminia T; Revankar S; Chandrasekar P
    Ann Hematol; 2016 Aug; 95(8):1323-7. PubMed ID: 27225264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salvage chemotherapy for refractory and relapsed posttransplant lymphoproliferative disorders (PTLD) after treatment with single-agent rituximab.
    Trappe R; Riess H; Babel N; Hummel M; Lehmkuhl H; Jonas S; Anagnostopoulos I; Papp-Vary M; Reinke P; Hetzer R; Dörken B; Oertel S
    Transplantation; 2007 Apr; 83(7):912-8. PubMed ID: 17460562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rituximab for Recurrence of Primary Focal Segmental Glomerulosclerosis After Kidney Transplantation: Clinical Outcomes.
    Garrouste C; Canaud G; Büchler M; Rivalan J; Colosio C; Martinez F; Aniort J; Dudreuilh C; Pereira B; Caillard S; Philipponnet C; Anglicheau D; Heng AE
    Transplantation; 2017 Mar; 101(3):649-656. PubMed ID: 27043407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of rituximab in pemphigus: experience of the German Registry of Autoimmune Diseases.
    Kasperkiewicz M; Eming R; Behzad M; Hunzelmann N; Meurer M; Schulze-Koops H; von Wussow P; Hertl M; Zillikens D; Freivogel K; Dörner T; Schmidt E
    J Dtsch Dermatol Ges; 2012 Oct; 10(10):727-32. PubMed ID: 22577946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.